ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Peptide-Based Drug Delivery System Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-3B18647
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Peptide Based Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Peptide-Based Drug Delivery System Market Research Report 2025

Code: QYRE-Auto-3B18647
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Sanofi
TEVA
Novo Nordisk
Takeda
Eli Lilly
Astrazeneca plc
Novartis
AbbVie
Ipsen S A
Ferring
Merck
The Medicines
Roche
J & J

Peptide-Based Drug Delivery System Market Size

The global market for Peptide-Based Drug Delivery System was valued at US$ 35190 million in the year 2024 and is projected to reach a revised size of US$ 47050 million by 2031, growing at a CAGR of 4.3% during the forecast period.

Peptide-Based Drug Delivery System Market

Peptide-Based Drug Delivery System Market

A peptide-based drug delivery system refers to a technology or formulation that utilizes peptides to improve the delivery, targeting, and release of therapeutic drugs. These systems are designed to enhance the efficacy, bioavailability, and safety of drugs by specifically delivering them to the desired site of action in the body.
Key market drivers for peptide-based drug delivery systems is the growing demand for targeted and personalized therapies. Peptides offer the advantage of high specificity and affinity for specific receptors or cell types, allowing for precise delivery of drugs to the desired sites in the body. This targeted approach enhances therapeutic efficacy while minimizing off-target effects and reducing systemic toxicity.
This report aims to provide a comprehensive presentation of the global market for Peptide-Based Drug Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-Based Drug Delivery System.
The Peptide-Based Drug Delivery System market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide-Based Drug Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide-Based Drug Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Peptide-Based Drug Delivery System Market Report

Report Metric Details
Report Name Peptide-Based Drug Delivery System Market
Accounted market size in year US$ 35190 million
Forecasted market size in 2031 US$ 47050 million
CAGR 4.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, Roche, J & J
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Peptide-Based Drug Delivery System company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Peptide-Based Drug Delivery System Market growing?

Ans: The Peptide-Based Drug Delivery System Market witnessing a CAGR of 4.3% during the forecast period 2025-2031.

What is the Peptide-Based Drug Delivery System Market size in 2031?

Ans: The Peptide-Based Drug Delivery System Market size in 2031 will be US$ 47050 million.

Who are the main players in the Peptide-Based Drug Delivery System Market report?

Ans: The main players in the Peptide-Based Drug Delivery System Market are Sanofi, Teva, Novo Nordisk, Takeda, Eli Lilly, AstraZeneca, Novartis, AbbVie, Ipsen, Ferring, Merck, The Medicines, Roche, J & J

What are the Application segmentation covered in the Peptide-Based Drug Delivery System Market report?

Ans: The Applications covered in the Peptide-Based Drug Delivery System Market report are Cancer, Metabolic Disorders, Central Nervous System, Other

What are the Type segmentation covered in the Peptide-Based Drug Delivery System Market report?

Ans: The Types covered in the Peptide-Based Drug Delivery System Market report are Brand, Generic Drug

Recommended Reports

Peptide Technology

Drug Delivery Systems

Healthcare Robotics & Apps

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide-Based Drug Delivery System Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Brand
1.2.3 Generic Drug
1.3 Market by Application
1.3.1 Global Peptide-Based Drug Delivery System Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide-Based Drug Delivery System Market Perspective (2020-2031)
2.2 Global Peptide-Based Drug Delivery System Growth Trends by Region
2.2.1 Global Peptide-Based Drug Delivery System Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide-Based Drug Delivery System Historic Market Size by Region (2020-2025)
2.2.3 Peptide-Based Drug Delivery System Forecasted Market Size by Region (2026-2031)
2.3 Peptide-Based Drug Delivery System Market Dynamics
2.3.1 Peptide-Based Drug Delivery System Industry Trends
2.3.2 Peptide-Based Drug Delivery System Market Drivers
2.3.3 Peptide-Based Drug Delivery System Market Challenges
2.3.4 Peptide-Based Drug Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide-Based Drug Delivery System Players by Revenue
3.1.1 Global Top Peptide-Based Drug Delivery System Players by Revenue (2020-2025)
3.1.2 Global Peptide-Based Drug Delivery System Revenue Market Share by Players (2020-2025)
3.2 Global Peptide-Based Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide-Based Drug Delivery System Revenue
3.4 Global Peptide-Based Drug Delivery System Market Concentration Ratio
3.4.1 Global Peptide-Based Drug Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide-Based Drug Delivery System Revenue in 2024
3.5 Global Key Players of Peptide-Based Drug Delivery System Head office and Area Served
3.6 Global Key Players of Peptide-Based Drug Delivery System, Product and Application
3.7 Global Key Players of Peptide-Based Drug Delivery System, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide-Based Drug Delivery System Breakdown Data by Type
4.1 Global Peptide-Based Drug Delivery System Historic Market Size by Type (2020-2025)
4.2 Global Peptide-Based Drug Delivery System Forecasted Market Size by Type (2026-2031)
5 Peptide-Based Drug Delivery System Breakdown Data by Application
5.1 Global Peptide-Based Drug Delivery System Historic Market Size by Application (2020-2025)
5.2 Global Peptide-Based Drug Delivery System Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide-Based Drug Delivery System Market Size (2020-2031)
6.2 North America Peptide-Based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide-Based Drug Delivery System Market Size by Country (2020-2025)
6.4 North America Peptide-Based Drug Delivery System Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide-Based Drug Delivery System Market Size (2020-2031)
7.2 Europe Peptide-Based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide-Based Drug Delivery System Market Size by Country (2020-2025)
7.4 Europe Peptide-Based Drug Delivery System Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide-Based Drug Delivery System Market Size (2020-2031)
8.2 Asia-Pacific Peptide-Based Drug Delivery System Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide-Based Drug Delivery System Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide-Based Drug Delivery System Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide-Based Drug Delivery System Market Size (2020-2031)
9.2 Latin America Peptide-Based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide-Based Drug Delivery System Market Size by Country (2020-2025)
9.4 Latin America Peptide-Based Drug Delivery System Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide-Based Drug Delivery System Market Size (2020-2031)
10.2 Middle East & Africa Peptide-Based Drug Delivery System Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide-Based Drug Delivery System Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide-Based Drug Delivery System Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Peptide-Based Drug Delivery System Introduction
11.1.4 Sanofi Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.1.5 Sanofi Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Peptide-Based Drug Delivery System Introduction
11.2.4 Teva Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.2.5 Teva Recent Development
11.3 Novo Nordisk
11.3.1 Novo Nordisk Company Details
11.3.2 Novo Nordisk Business Overview
11.3.3 Novo Nordisk Peptide-Based Drug Delivery System Introduction
11.3.4 Novo Nordisk Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.3.5 Novo Nordisk Recent Development
11.4 Takeda
11.4.1 Takeda Company Details
11.4.2 Takeda Business Overview
11.4.3 Takeda Peptide-Based Drug Delivery System Introduction
11.4.4 Takeda Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.4.5 Takeda Recent Development
11.5 Eli Lilly
11.5.1 Eli Lilly Company Details
11.5.2 Eli Lilly Business Overview
11.5.3 Eli Lilly Peptide-Based Drug Delivery System Introduction
11.5.4 Eli Lilly Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.5.5 Eli Lilly Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Peptide-Based Drug Delivery System Introduction
11.6.4 AstraZeneca Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Peptide-Based Drug Delivery System Introduction
11.7.4 Novartis Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.7.5 Novartis Recent Development
11.8 AbbVie
11.8.1 AbbVie Company Details
11.8.2 AbbVie Business Overview
11.8.3 AbbVie Peptide-Based Drug Delivery System Introduction
11.8.4 AbbVie Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.8.5 AbbVie Recent Development
11.9 Ipsen
11.9.1 Ipsen Company Details
11.9.2 Ipsen Business Overview
11.9.3 Ipsen Peptide-Based Drug Delivery System Introduction
11.9.4 Ipsen Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.9.5 Ipsen Recent Development
11.10 Ferring
11.10.1 Ferring Company Details
11.10.2 Ferring Business Overview
11.10.3 Ferring Peptide-Based Drug Delivery System Introduction
11.10.4 Ferring Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.10.5 Ferring Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Peptide-Based Drug Delivery System Introduction
11.11.4 Merck Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.11.5 Merck Recent Development
11.12 The Medicines
11.12.1 The Medicines Company Details
11.12.2 The Medicines Business Overview
11.12.3 The Medicines Peptide-Based Drug Delivery System Introduction
11.12.4 The Medicines Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.12.5 The Medicines Recent Development
11.13 Roche
11.13.1 Roche Company Details
11.13.2 Roche Business Overview
11.13.3 Roche Peptide-Based Drug Delivery System Introduction
11.13.4 Roche Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.13.5 Roche Recent Development
11.14 J & J
11.14.1 J & J Company Details
11.14.2 J & J Business Overview
11.14.3 J & J Peptide-Based Drug Delivery System Introduction
11.14.4 J & J Revenue in Peptide-Based Drug Delivery System Business (2020-2025)
11.14.5 J & J Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Sanofi
TEVA
Novo Nordisk
Takeda
Eli Lilly
Astrazeneca plc
Novartis
AbbVie
Ipsen S A
Ferring
Merck
The Medicines
Roche
J & J
List of Tables
 Table 1. Global Peptide-Based Drug Delivery System Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Brand
 Table 3. Key Players of Generic Drug
 Table 4. Global Peptide-Based Drug Delivery System Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Peptide-Based Drug Delivery System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Peptide-Based Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Peptide-Based Drug Delivery System Market Share by Region (2020-2025)
 Table 8. Global Peptide-Based Drug Delivery System Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Peptide-Based Drug Delivery System Market Share by Region (2026-2031)
 Table 10. Peptide-Based Drug Delivery System Market Trends
 Table 11. Peptide-Based Drug Delivery System Market Drivers
 Table 12. Peptide-Based Drug Delivery System Market Challenges
 Table 13. Peptide-Based Drug Delivery System Market Restraints
 Table 14. Global Peptide-Based Drug Delivery System Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Peptide-Based Drug Delivery System Market Share by Players (2020-2025)
 Table 16. Global Top Peptide-Based Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Based Drug Delivery System as of 2024)
 Table 17. Ranking of Global Top Peptide-Based Drug Delivery System Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Peptide-Based Drug Delivery System Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Peptide-Based Drug Delivery System, Headquarters and Area Served
 Table 20. Global Key Players of Peptide-Based Drug Delivery System, Product and Application
 Table 21. Global Key Players of Peptide-Based Drug Delivery System, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Peptide-Based Drug Delivery System Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Peptide-Based Drug Delivery System Revenue Market Share by Type (2020-2025)
 Table 25. Global Peptide-Based Drug Delivery System Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Peptide-Based Drug Delivery System Revenue Market Share by Type (2026-2031)
 Table 27. Global Peptide-Based Drug Delivery System Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Peptide-Based Drug Delivery System Revenue Market Share by Application (2020-2025)
 Table 29. Global Peptide-Based Drug Delivery System Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Peptide-Based Drug Delivery System Revenue Market Share by Application (2026-2031)
 Table 31. North America Peptide-Based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Peptide-Based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Peptide-Based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Peptide-Based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Peptide-Based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Peptide-Based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Peptide-Based Drug Delivery System Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Peptide-Based Drug Delivery System Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Peptide-Based Drug Delivery System Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Peptide-Based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Peptide-Based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Peptide-Based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Peptide-Based Drug Delivery System Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Peptide-Based Drug Delivery System Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Peptide-Based Drug Delivery System Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Sanofi Company Details
 Table 47. Sanofi Business Overview
 Table 48. Sanofi Peptide-Based Drug Delivery System Product
 Table 49. Sanofi Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 50. Sanofi Recent Development
 Table 51. Teva Company Details
 Table 52. Teva Business Overview
 Table 53. Teva Peptide-Based Drug Delivery System Product
 Table 54. Teva Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 55. Teva Recent Development
 Table 56. Novo Nordisk Company Details
 Table 57. Novo Nordisk Business Overview
 Table 58. Novo Nordisk Peptide-Based Drug Delivery System Product
 Table 59. Novo Nordisk Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 60. Novo Nordisk Recent Development
 Table 61. Takeda Company Details
 Table 62. Takeda Business Overview
 Table 63. Takeda Peptide-Based Drug Delivery System Product
 Table 64. Takeda Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 65. Takeda Recent Development
 Table 66. Eli Lilly Company Details
 Table 67. Eli Lilly Business Overview
 Table 68. Eli Lilly Peptide-Based Drug Delivery System Product
 Table 69. Eli Lilly Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 70. Eli Lilly Recent Development
 Table 71. AstraZeneca Company Details
 Table 72. AstraZeneca Business Overview
 Table 73. AstraZeneca Peptide-Based Drug Delivery System Product
 Table 74. AstraZeneca Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 75. AstraZeneca Recent Development
 Table 76. Novartis Company Details
 Table 77. Novartis Business Overview
 Table 78. Novartis Peptide-Based Drug Delivery System Product
 Table 79. Novartis Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 80. Novartis Recent Development
 Table 81. AbbVie Company Details
 Table 82. AbbVie Business Overview
 Table 83. AbbVie Peptide-Based Drug Delivery System Product
 Table 84. AbbVie Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 85. AbbVie Recent Development
 Table 86. Ipsen Company Details
 Table 87. Ipsen Business Overview
 Table 88. Ipsen Peptide-Based Drug Delivery System Product
 Table 89. Ipsen Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 90. Ipsen Recent Development
 Table 91. Ferring Company Details
 Table 92. Ferring Business Overview
 Table 93. Ferring Peptide-Based Drug Delivery System Product
 Table 94. Ferring Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 95. Ferring Recent Development
 Table 96. Merck Company Details
 Table 97. Merck Business Overview
 Table 98. Merck Peptide-Based Drug Delivery System Product
 Table 99. Merck Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 100. Merck Recent Development
 Table 101. The Medicines Company Details
 Table 102. The Medicines Business Overview
 Table 103. The Medicines Peptide-Based Drug Delivery System Product
 Table 104. The Medicines Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 105. The Medicines Recent Development
 Table 106. Roche Company Details
 Table 107. Roche Business Overview
 Table 108. Roche Peptide-Based Drug Delivery System Product
 Table 109. Roche Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 110. Roche Recent Development
 Table 111. J & J Company Details
 Table 112. J & J Business Overview
 Table 113. J & J Peptide-Based Drug Delivery System Product
 Table 114. J & J Revenue in Peptide-Based Drug Delivery System Business (2020-2025) & (US$ Million)
 Table 115. J & J Recent Development
 Table 116. Research Programs/Design for This Report
 Table 117. Key Data Information from Secondary Sources
 Table 118. Key Data Information from Primary Sources
 Table 119. Authors List of This Report


List of Figures
 Figure 1. Peptide-Based Drug Delivery System Picture
 Figure 2. Global Peptide-Based Drug Delivery System Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Peptide-Based Drug Delivery System Market Share by Type: 2024 VS 2031
 Figure 4. Brand Features
 Figure 5. Generic Drug Features
 Figure 6. Global Peptide-Based Drug Delivery System Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Peptide-Based Drug Delivery System Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Metabolic Disorders Case Studies
 Figure 10. Central Nervous System Case Studies
 Figure 11. Other Case Studies
 Figure 12. Peptide-Based Drug Delivery System Report Years Considered
 Figure 13. Global Peptide-Based Drug Delivery System Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Peptide-Based Drug Delivery System Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Peptide-Based Drug Delivery System Market Share by Region: 2024 VS 2031
 Figure 16. Global Peptide-Based Drug Delivery System Market Share by Players in 2024
 Figure 17. Global Top Peptide-Based Drug Delivery System Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Based Drug Delivery System as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Peptide-Based Drug Delivery System Revenue in 2024
 Figure 19. North America Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Peptide-Based Drug Delivery System Market Share by Country (2020-2031)
 Figure 21. United States Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Peptide-Based Drug Delivery System Market Share by Country (2020-2031)
 Figure 25. Germany Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Peptide-Based Drug Delivery System Market Share by Region (2020-2031)
 Figure 33. China Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Peptide-Based Drug Delivery System Market Share by Country (2020-2031)
 Figure 41. Mexico Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Peptide-Based Drug Delivery System Market Share by Country (2020-2031)
 Figure 45. Turkey Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Peptide-Based Drug Delivery System Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Sanofi Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 49. Teva Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 50. Novo Nordisk Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 51. Takeda Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 52. Eli Lilly Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 53. AstraZeneca Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 54. Novartis Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 55. AbbVie Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 56. Ipsen Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 57. Ferring Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 58. Merck Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 59. The Medicines Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 60. Roche Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 61. J & J Revenue Growth Rate in Peptide-Based Drug Delivery System Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Peptide based Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Based Cancer Therapeutics Market Research Report 2024
Global Peptide based Generics Market Research Report 2024
Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nano based Drug Delivery System Market Research Report 2024
Global Nanotechnology based Drug Delivery Systems Market Research Report 2024
Global Oral Peptide Drugs Market Research Report 2024
Liposomal based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Peptide Therapy Market Research Report 2025
Global Targeting Peptides Market Research Report 2024
Global Targeted Drug Delivery System Market Research Report 2025
Global Pharmaceutical Drug Delivery Technologies Market Insights Forecast to 2030
Liposomal and Lipid based Nanoparticle Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Peptide based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal and Lipid Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomes Nanocarrier Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposomal Drug delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Liposome Finished Pharmaceuticals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nanotechnology in Targeted Drug Delivery Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions